Cargando...
Cornerstones of CRISPR-Cas in drug development and therapy
The recent development of CRISPR-Cas systems as easily accessible and programmable tools for genome editing and regulation is spurring a revolution in biology. Paired with the rapid expansion of personalized and reference genomic sequence information, technologies based on CRISPR-Cas are enabling ne...
Gardado en:
| Publicado en: | Nat Rev Drug Discov |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5459481/ https://ncbi.nlm.nih.gov/pubmed/28008168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd.2016.238 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|